J Claude Bennett - Net Worth and Insider Trading
J Claude Bennett Net Worth
The estimated net worth of J Claude Bennett is at least $349,684 dollars as of 2024-05-13. J Claude Bennett is the COO of BioCryst Pharmaceuticals Inc and owns about 65,730 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $349,684. Details can be seen in J Claude Bennett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that J Claude Bennett has not made any transactions after 2007-09-04 and currently still holds the listed stock(s).
Transaction Summary of J Claude Bennett
J Claude Bennett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J Claude Bennett owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of J Claude Bennett’s form 4 insider trades.
Insider Ownership Summary of J Claude Bennett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2007-09-04 | director & President |
J Claude Bennett Latest Holdings Summary
J Claude Bennett currently owns a total of 1 stock. J Claude Bennett owns 65,730 shares of BioCryst Pharmaceuticals Inc (BCRX) as of September 4, 2007, with a value of $349,684.
Latest Holdings of J Claude Bennett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2007-09-04 | 65,730 | 5.32 | 349,684 |
Holding Weightings of J Claude Bennett
J Claude Bennett Form 4 Trading Tracker
According to the SEC Form 4 filings, J Claude Bennett has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 20,000 shares on September 4, 2007, which brought J Claude Bennett around $240,000.
Insider Trading History of J Claude Bennett
- 1
J Claude Bennett Trading Performance
GuruFocus tracks the stock performance after each of J Claude Bennett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J Claude Bennett is -39.33%. GuruFocus also compares J Claude Bennett's trading performance to market benchmark return within the same time period. The performance of stocks bought by J Claude Bennett within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how J Claude Bennett's insider trading performs compared to the benchmark.
Performance of J Claude Bennett
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.25 | | | | | |
| Relative Return to S&P 500(%) | -11.92 | | | | | |
J Claude Bennett Ownership Network
J Claude Bennett Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
J Claude Bennett is the director & President of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include director & CEO Jon P Stonehouse , Vice President and CCO Charles K Gayer , and Exec Director & Finance - PAO Michael L Jones .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, J Claude Bennett made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 411,673 shares made by Jon P Stonehouse , a net sale of 10,125 shares made by Helen M. Thackray , and a net sale of 9,045 shares made by Michael L Jones .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 495,199 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 495,199 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
J Claude Bennett Mailing Address
Above is the net worth, insider trading, and ownership report for J Claude Bennett. You might contact J Claude Bennett via mailing address: C/o Biocryst Pharmaceuticals, Inc, 2190 Pkwy Lake Drive, Birmingham Al 35244.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
